Segall Bryant & Hamill’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Buy
115,497
+31,728
+38% +$5.29M 0.21% 175
2026
Q1
$17.6M Sell
83,769
-16,537
-16% -$4.16M 0.25% 144
2025
Q4
$28.5M Buy
100,306
+1,420
+1% +$444K 0.39% 74
2025
Q3
$30.5M Buy
98,886
+5,254
+6% +$1.65M 0.41% 66
2025
Q2
$29.4M Buy
93,632
+3,300
+4% +$952K 0.41% 67
2025
Q1
$23.7M Buy
90,332
+18,567
+26% +$5.02M 0.36% 86
2024
Q4
$18.7M Buy
71,765
+8,713
+14% +$2.19M 0.26% 121
2024
Q3
$14.7M Buy
63,052
+15,683
+33% +$3.22M 0.2% 160
2024
Q2
$9.56M Buy
47,369
+1,572
+3% +$283K 0.17% 196
2024
Q1
$7.85M Buy
45,797
+1,247
+3% +$233K 0.15% 227
2023
Q4
$9.67M Buy
44,550
+1,403
+3% +$241K 0.19% 189
2023
Q3
$6.88M Sell
43,147
-29,072
-40% -$6.51M 0.08% 272
2023
Q2
$20.8M Buy
72,219
+503
+0.7% +$153K 0.22% 128
2023
Q1
$22.9M Buy
71,716
+3,126
+5% +$927K 0.25% 120
2022
Q4
$20.2M Sell
68,590
-1,174
-2% -$324K 0.23% 134
2022
Q3
$16M Buy
69,764
+8,404
+14% +$2.1M 0.19% 144
2022
Q2
$13.4M Buy
61,360
+2,458
+4% +$559K 0.15% 163
2022
Q1
$15.7M Buy
58,902
+6,819
+13% +$1.67M 0.15% 162
2021
Q4
$13.9M Sell
52,083
-9,256
-15% -$2.69M 0.13% 179
2021
Q3
$17.4M Sell
61,339
-132
-0.2% -$37.6K 0.17% 152
2021
Q2
$16.9M Buy
61,471
+16,857
+38% +$4.58M 0.16% 159
2021
Q1
$11.6M Sell
44,614
-11,509
-21% -$3.08M 0.12% 192
2020
Q4
$14.3M Buy
56,123
+2,902
+5% +$720K 0.16% 156
2020
Q3
$12.6M Buy
53,221
+4,123
+8% +$868K 0.17% 136
2020
Q2
$9.54M Sell
49,098
-7,215
-13% -$1.38M 0.16% 133
2020
Q1
$9.33M Sell
56,313
-813
-1% -$149K 0.19% 112
2019
Q4
$9.78M Sell
57,126
-41,147
-42% -$6.86M 0.15% 146
2019
Q3
$16.2M Sell
98,273
-24,128
-20% -$3.39M 0.25% 103
2019
Q2
$14.6M Sell
122,401
-15,573
-11% -$1.6M 0.22% 119
2019
Q1
$13.1M Sell
137,974
-2,226
-2% -$191K 0.2% 133
2018
Q4
$11.1M Buy
140,200
+2,874
+2% +$243K 0.19% 141
2018
Q3
$14.6M Sell
137,326
-9,443
-6% -$884K 0.21% 136
2018
Q2
$12.6M Sell
146,769
-25,514
-15% -$2.29M 0.19% 153
2018
Q1
$14.9M Sell
172,283
-28,424
-14% -$2.21M 0.35% 79
2017
Q4
$13.8M Buy
200,707
+19,105
+11% +$1.25M 0.3% 92
2017
Q3
$10M Sell
181,602
-18,973
-9% -$1.04M 0.23% 107
2017
Q2
$10.3M Sell
200,575
-45,465
-18% -$1.97M 0.24% 99
2017
Q1
$10.6M Sell
246,040
-5,701
-2% -$245K 0.26% 104
2016
Q4
$9.49M Sell
251,741
-4,815
-2% -$179K 0.24% 112
2016
Q3
$10.5M Sell
256,556
-1,175
-0.5% -$46.5K 0.27% 104
2016
Q2
$7.79M Sell
257,731
-28,735
-10% -$894K 0.21% 126
2016
Q1
$9.5M Sell
286,466
-50,344
-15% -$1.58M 0.24% 123
2015
Q4
$12.7M Sell
336,810
-14,575
-4% -$491K 0.31% 100
2015
Q3
$9.1M Buy
351,385
+67,404
+24% +$2.04M 0.22% 122
2015
Q2
$8.8M Sell
283,981
-3,247
-1% -$95.7K 0.2% 152
2015
Q1
$9.58M Buy
+287,228
New +$9.7M 0.22% 145

Other funds holding PODD

Segall Bryant & Hamill's PODD Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Insulet (PODD) stake by 38% in Q2 2026, buying an estimated $5.29M and bringing the position to 115,497 shares worth $17.6M. The position accounts for 0.21% of the portfolio, ranked #175.

Segall Bryant & Hamill first reported a position in PODD in Q1 2015 and has held it in 46 quarters since. The position peaked at $30.5M in Q3 2025. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Segall Bryant & Hamill held 115,497 shares of Insulet worth $17.6M as of Q2 2026.
  • Segall Bryant & Hamill bought 31,728 Insulet shares in Q2 2026, an estimated $5.29M.
  • Insulet made up 0.21% of Segall Bryant & Hamill's portfolio in Q2 2026, its #175 holding.
  • Segall Bryant & Hamill first reported a position in Insulet in Q1 2015 and has held it in 46 quarters since.
  • Segall Bryant & Hamill's Insulet position peaked at $30.5M in Q3 2025.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.